Elucidata builds algorithms and software to process, analyze, and visualize large omics data from studies like metabolomics, genomics, transcriptomics, and proteomics, among others.
The company is headquartered in India.
Funding details
- Funding amount: US$16,000,000
- Lead investors: Eight Roads Ventures
- Other investors: F-Prime Capital, IvyCap Ventures, Hyperplane Venture Capital
- Stage: Series A
- Source
More details
Elucidata has raised US$22.7 million in total funding to date.
| Stage | Amount (US$) | Investors |
| Seed | 1,700,000 | Hyperplane Venture Capital |
| Pre-series A | 5,000,000 | IvyCap Ventures, Hyperplane Venture Capital |
| Series A | 16,000,000 | IvyCap Ventures, F-Prime Capital, Hyperplane Venture Capital , Eight Roads (Fidelity Ventures) (斯道资本) |
Elucidata was founded in 2015 by Abhishek Jha, Swetabh Pathak, and Richard Kibbey. The fresh funds will be used to scale the company’s go-to-market initiatives, accelerate global expansion, and deepen product capabilities in translational drug research and allied markets.
Editing by Miguel Cordon and Jaclyn Tiu
(And yes, we’re serious about ethics and transparency. More information here.)
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.
